Share

August 07, 2018; 91 (6) NeuroImages

Coxa saltans misdiagnosed as functional gait disorder

Two cases

Donald L. Gilbert, Alberto J. Espay, Steve W. Wu
First published August 6, 2018, DOI: https://doi.org/10.1212/WNL.0000000000005955
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
644

Share

Article Information

vol. 91 no. 6 276-277
DOI: 
https://doi.org/10.1212/WNL.0000000000005955
PubMed: 
30082438
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published August 6, 2018.
Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Donald L. Gilbert, MD, MS,
    2. Alberto J. Espay, MD, MSc and
    3. Steve W. Wu, MD
  1. Donald L. Gilbert, MD, MS,
    2. Scientific Advisory Boards:

    1. Tourette Association of America Scientific Advisory Board - non-profit

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Tourette Association of America / Centers for Disease Control and Prevention: Honoraria, travel expenses for educational talks to physicians and affected patients and families. American Academy of Pediatrics - travel expenses, honorarium for teaching. Child Neurology Society for service on executive board.

    Editorial Boards:

    1. Associate editor for Pediatric Neurology.

    Patents:

    1. NONE

    Publishing Royalties:

    1. Royalties for: Movement Disorders in Childhood, 2nd edition. Author(s): Harvey S. Singer, MD, Jonathan W. Mink, MD, PhD, Donald L. Gilbert, MD, and Joseph Jankovic, MD Elsevier 2015. Pediatric Brain Stimulation. Editors: Adam Kirton, Donald L Gilbert. Elsevier 2016. Up to Date - Wolters Kluwer.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Psyadon Pharmaceuticals, EryDel Pharmaceuticals. Clinical trials site investigator. Research work only, plus travel to investigator start up meetings.

    Research Support, Government Entities:

    1. R01 NS096207 2016-2021 Co-PI; R01 MH095014 2012-2018 Co- PI; R01 NS085023 2014-2019 Researcher;

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Tourette Association of America, research grant.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Expert Testimony: the U.S. National Vaccine Injury Compensation Program, through the Department of Health and Human Services

  2. Alberto J. Espay, MD, MSc and
    3. Scientific Advisory Boards:

    1. Abbvie, NeuroDerm, TEVA, Impax, Acadia, Acorda, Cynapsus/Sunovion, Lundbeck, Osmotica Pharmaceutical, and USWorldMeds

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial board member of the Journal of Parkinson?s Disease and Parkinsonism and Related Disorders.

    Patents:

    1. NONE

    Publishing Royalties:

    1. Lippincott Williams & Wilkins, Cambridge University Press, and Springer.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant for Abbvie, NeuroDerm, TEVA, Impax, Acadia, Acorda, Cynapsus/Sunovion, Lundbeck, Osmotica Pharmaceutical, and USWorldMeds

    Speakers' Bureaus:

    1. Abbvie, UCB, USWorldMeds, Lundbeck, Acadia, the American Academy of Neurology, and the Movement Disorders Society

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH

    Research Support, Academic Entities:

    1. Great Lakes Neurotechnologies

    Research Support, Foundations and Societies:

    1. Michael J Fox Foundation, Davis Phinney Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Steve W. Wu, MD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Site PI for multi-center clinical trial for Ataxia Telangiectasis (EryDel, S.p.A.).

    Research Support, Government Entities:

    1. (1) NINDS, grant number 5R01NS096207, subinvestigator, year 2 of 5

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Tourette Association of America

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Division of Neurology, Department of Pediatrics (D.L.G., S.W.W.), Cincinnati Children's Hospital Medical Center and University of Cincinnati; and Department of Neurology (A.J.E.), Gardner Center for Parkinson's Disease and Movement Disorders, UC Gardner Neuroscience Institute, University of Cincinnati, OH.
  1. Correspondence
    Dr. Wu steve.wu{at}cchmc.org
View Full Text

Article usage

Article usage: August 2018 to March 2023

AbstractFullPdfSource
Aug 201896775135Highwire
Sep 201808428Highwire
Oct 2018024125Highwire
Nov 20180585Highwire
Dec 201805314Highwire
Jan 20191344Highwire
Feb 20193447Highwire
Mar 201916513Highwire
Apr 20190379Highwire
May 20191286Highwire
Jun 20190339Highwire
Jul 201912614Highwire
Aug 20190387Highwire
Sep 20190328Highwire
Oct 20192294Highwire
Nov 201913822Highwire
Dec 20190193Highwire
Jan 20203252Highwire
Feb 202002411Highwire
Mar 202002312Highwire
Apr 20200319Highwire
May 20200208Highwire
Jun 20202198Highwire
Jul 20200273Highwire
Aug 20200228Highwire
Sep 20201162Highwire
Oct 202002713Highwire
Nov 202013519Highwire
Dec 20200345Highwire
Jan 20210158Highwire
Feb 20210173Highwire
Mar 202105317Highwire
Apr 20210674Highwire
May 202116813Highwire
Jun 20210504Highwire
Jul 202114314Highwire
Aug 202114510Highwire
Sep 202115111Highwire
Oct 202106223Highwire
Nov 202104016Highwire
Dec 202103010Highwire
Jan 20220567Highwire
Feb 20220525Highwire
Mar 20220449Highwire
Apr 20221506Highwire
May 202214312Highwire
Jun 20220266Highwire
Jul 20220572Highwire
Aug 202205610Highwire
Sep 202208312Highwire
Oct 20221606Highwire
Nov 20220677Highwire
Dec 20220357Highwire
Jan 20231635Highwire
Feb 20230564Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles